BPI | Bactericidal/permeability-increasing protein | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BPIFA1 | BPI fold containing family A, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
BPIFA2 | BPI fold containing family A, member 2 | Predicted secreted proteins
| | | | | Tissue enriched |
BPIFA3 | BPI fold containing family A, member 3 | Predicted secreted proteins
| | | | | Tissue enriched |
BPIFB1 | BPI fold containing family B, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BPIFB2 | BPI fold containing family B, member 2 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
BSG | Basigin (Ok blood group) | Blood group antigen proteins CD markers Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BTN3A3 | Butyrophilin, subfamily 3, member A3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
C10orf99 | Chromosome 10 open reading frame 99 | Predicted secreted proteins
| | | | | Group enriched |
C16orf89 | Chromosome 16 open reading frame 89 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
C19orf10 | Chromosome 19 open reading frame 10 | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
C1GALT1 | Core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
C1orf56 | Chromosome 1 open reading frame 56 | Predicted secreted proteins
| | | | | Tissue enriched |
C1QA | Complement component 1, q subcomponent, A chain | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
C1QTNF9 | C1q and tumor necrosis factor related protein 9 | Predicted secreted proteins
| | | | | Tissue enhanced |
C1S | Complement component 1, s subcomponent | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
C2 | Complement component 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
C21orf33 | Chromosome 21 open reading frame 33 | Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
C2CD2 | C2 calcium-dependent domain containing 2 | Predicted secreted proteins
| | | | | Expressed in all |
C3 | Complement component 3 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C4A | Complement component 4A (Rodgers blood group) | Blood group antigen proteins Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
C4B | Complement component 4B (Chido blood group) | Blood group antigen proteins Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
C4BPA | Complement component 4 binding protein, alpha | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C4orf40 | Chromosome 4 open reading frame 40 | Predicted secreted proteins
| | | | | Tissue enriched |
C6 | Complement component 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
C8B | Complement component 8, beta polypeptide | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CA6 | Carbonic anhydrase VI | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CACNA2D1 | Calcium channel, voltage-dependent, alpha 2/delta subunit 1 | FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CADM1 | Cell adhesion molecule 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
CADM3 | Cell adhesion molecule 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CALR3 | Calreticulin 3 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CALU | Calumenin | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CAMP | Cathelicidin antimicrobial peptide | Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CARM1 | Coactivator-associated arginine methyltransferase 1 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CARNS1 | Carnosine synthase 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
CASQ1 | Calsequestrin 1 (fast-twitch, skeletal muscle) | Mitochondrial proteins Predicted secreted proteins
| | | | | Tissue enriched |
CASQ2 | Calsequestrin 2 (cardiac muscle) | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
CCDC112 | Coiled-coil domain containing 112 | Predicted secreted proteins
| | | | | Tissue enhanced |
CCL21 | Chemokine (C-C motif) ligand 21 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CCNDBP1 | Cyclin D-type binding-protein 1 | Predicted secreted proteins
| | | | | Expressed in all |
CCNL2 | Cyclin L2 | Predicted secreted proteins
| | | | | Expressed in all |
CD14 | CD14 molecule | Cancer-related genes CD markers Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CD164L2 | CD164 sialomucin-like 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD2 | CD2 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD22 | CD22 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD226 | CD226 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD276 | CD276 molecule | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |